DASATINIB 100 MG ONCE DAILY FOR CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) FOLLOWING IMATINIB FAILURE: LONG-TERM FOLLOW-UP FROM STUDY CA180-034

被引：0

作者：

Hochhaus, A. ^{[1
]}

Kim, D. W. ^{[2
]}

Kantarjian, H. M. ^{[3
]}

Rousselot, P. ^{[4
,5
]}

Dorlhiac-Llacer, P. ^{[6
]}

Milone, J. ^{[7
]}

Shah, N. P. ^{[8
]}

Matloub, Y. ^{[9
]}

Lambert, A. ^{[9
]}

Stone, R. M. ^{[10
]}

机构：

[1] Univ Med Mannheim, Mannheim, Germany

[2] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea

[3] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Univ Versailles, Hop Mignot, Le Chesnay, France

[5] CIC9504, Le Chesnay, France

[6] Univ Sao Paulo, Hosp Clin, Sao Paulo, Brazil

[7] Inst Trasplante Medula Osea, La Plata, Buenos Aires, Argentina

[8] Univ Calif San Francisco, San Francisco Sch Med, San Francisco, CA 94143 USA

[9] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1091

引用

页码：441 / 441

页数：1